Security key
04280A100
ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (ARWR)
CUSIP: 04280A100
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 96,658,787
- Total 13F value
- $2,763,026,175
- Share change
- +19,295,333
- Put/Call ratio
- 43%
- SEC-reported price per share
- $28.60
- Number of holders
- 267
- Value change
- +$544,741,705
- Number of buys
- 141
- Number of sells
- 101
- Shares outstanding
- 141,020,453
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
267
Top holders
10
ARWR full security history
Ownership snapshot
Full 13F holder table
ARROWHEAD PHARMACEUTICALS, INC. SEC filings
ARROWHEAD PHARMACEUTICALS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of ARWR - ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F
Highest disclosed value: $407,094,965
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. has the largest disclosed position value at $407.09M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value
Top 5
BlackRock Finance, Inc.
$407.09M
VANGUARD GROUP INC
$326.57M
STATE STREET CORP
$208.85M
JPMORGAN CHASE & CO
$84.18M
GEODE CAPITAL MANAGEMENT, LLC
$71.21M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$407,094,965
13,303,757 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$326,565,525
10,672,076 shares
|
— | 31 Dec 2023 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$208,848,397
6,825,111 shares
|
— | 31 Dec 2023 |
| JPMORGAN CHASE & CO |
13F
Company
|
—
denominator unverified
|
$84,182,068
2,751,048 shares
|
— | 31 Dec 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$71,210,442
2,326,876 shares
|
— | 31 Dec 2023 |
| Invesco Ltd. |
13F
Company
|
—
denominator unverified
|
$70,573,024
2,306,308 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
267
Shares
96,658,787
Rows available
267
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
267
Q1 2024 holders
267
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|